«Vascular

Below is an extended Vascular patents listing. Click here to return to the Vascular main in depth entry.

Patents :
US Patent No.	Title
7416857	Differential diagnosis with hepcidin
7417038	Methods of treating cachexia
7417039	Use of substituted azetidinone compounds for the treatment of sitosterolemia
7417042	Compounds for enzyme inhibition
7417043	Modulators of dopamine neurotransmission
7417047	Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for .beta.-secretase modulation
7417055	Kinase inhibitory phosphonate analogs
7417056	5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
7417057	Pesticidal heterocycles
7417058	Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
7417059	Substituted aromatic-ring compounds, process for producing the same and use
7417035	Phospholipid derivatives of non-steroidal anti-inflammatory drugs
7417033	Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells
7417031	Use of algae-derived physiologically active substances for treating a carcinomatous disease
7416858	Pharmaceutical compositions of glycoconjugates
7416860	Nucleic acids encoding human coagulation factor VII variants
7416861	Human coagulation factor VII polypeptides
7416868	Polyene polyketides, processes for their production and their use as a pharmaceutical
7416881	Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
7416885	Proliferated cell lines and uses thereof
7417023	Targeted delivery of bioaffecting compounds for the treatment of cancer
7417028	Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions
7417029	Prodrug of an ice inhibitor
7417030	Indazole peptidomimetics as thrombin receptor antagonists
7417063	Bicyclic heterocycles useful as serine protease inhibitors
7417065	Immunosuppressant compounds and compositions
7417137	Non-squamous epithelium-specific transcription
7417144	Factor Xa inhibitors
7417152	4-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin B.sub.1 receptor antagonists for the treatment of inflammatory diseases
7417174	Resorbable laminated repair film and method of using same
7417727	Method and apparatus for standoff detection of liveness
7417730	Apparatus and method for monitoring breath acetone and diabetic diagnostics
7418116	Imaging method and system
7418151	Systems and methods for optimized region growing algorithm for scale space analysis
7418169	Apparatus for controlling at least one of at least two sections of at least one fiber
7418292	Device and method for attenuating an immune response
7417127	Antibodies specific for CD44v6
7417126	PRO246 antibodies
7417125	Antibodies that bind a PRO1158 polypeptide
7417068	EP.sub.4 receptor antagonists
7417069	Halogenated triptolide derivatives as immunomodulators and anticancer agents
7417070	Compounds and methods for delivery of prostacyclin analogs
7417072	Blockade of Pin1 prevents cytokine production by activated immune cells
7417096	Preparation of transition metal nanoparticles and surfaces modified with (CO) polymers synthesized by RAFT
7417109	Polymers for delivering nitric oxide in vivo
7417115	PRO6027 polypeptides
7417116	PRO7155 polypeptides
7417121	Human G-protein coupled receptor, HGPRBMY39
7417123	PRO4399 Antibodies
7418374	Treatment protocol generation for diseases related to angiogenesis

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.